Cureus·Nov 8Rapid Eye Movement Sleep Behavior Disorder as a Prodromal Manifestation of Alpha-SynucleinopathiesReviewMechanismsPaper
Journal of Parkinson's Disease·Jul 24Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathiesReviewIndustry & policyPaper
Journal of Sleep Research·Nov 28Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristicsStudy protocolNeurodegenerative diseasePaper